A new family of biodegradable and charged hybrid hydrogels was designed and fabricated via photo-crosslinking in an aqueous medium from a hyaluronic acid (HA) precursor and a relatively new amino acid-based poly(ester amide) (AA-PEA) precursor. The HA precursor was synthesized by incorporating an unsaturated moiety (aminoethyl methacrylate, AEMA), while the AA-PEA precursor was synthesized from unsaturated arginine-based poly(ester amide)s (UArg-PEA). These two water soluble precursors were photo-crosslinked to formulate a new family of biodegradable hybrid hydrogels. The chemical structure of these hybrid hydrogels was characterized, and their swelling, mechanical, morphological, biodegradation and drug release properties were examined as a function of the feed ratio of these 2 precursors and the degree of substitution (DS) of AEMA groups in HA-AEMA. The resulting hybrid hydrogels showed a 400–600% swelling ratio, and pH dependent swelling was observed only in a pure HA-AEMA hydrogel. The hybrid hydrogels showed a distinctive sheet-like multi-layered 3D microporous structure confirmed by SEM. Upon trypsin catalyzed biodegradation, the hybrid hydrogels showed 50 to 70% weight loss within 6 days, while the same hybrid hydrogels showed less than 5% weight loss in a PBS medium. The hybrid hydrogels showed a sustained release of bovine serum albumin (BSA) over 25 h, while the pure HA-AEMA hydrogel exhibited a complete release of BSA within 5 h. When compared with a pure HA-AEMA hydrogel, the cationic Arg-PEA/HA-AEMA hybrid hydrogels significantly improved the attachment and proliferation of Hela cells on hydrogel surfaces.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: